Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Spedding

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Neuropharmacology|September 27, 2008
Ligand gated ion channelsGraham L Collingridge, Richard Olsen, John A Peters, et al.
Brain Research|April 23, 2003
Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brainEleni Dicou, Claire-Marie Rangon, Fabien Guimiot, et al.
Biochemical Pharmacology|July 2, 2017
Joint ICMAN and IUPHAR natural products section meeting. Aberdeen UK 27-29th September 2017Yongxiang Zhang, Michael Spedding, Cherry Wainwright, et al.
Nature Reviews. Drug Discovery|June 3, 2005
A pathophysiological paradigm for the therapy of psychiatric diseaseMichael Spedding, Thérèse Jay, Jorge Costa e Silva, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 22, 2013
The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?Bill P Godsil, Janos P Kiss, Michael Spedding, et al.
European Journal of Pharmacology|August 23, 2002
Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2'-pyridylisatogen tosylate and related compoundsKevin Menton, Michael Spedding, Pierre Gressens, et al.
Indian Journal of Pharmacology|March 28, 2022
Aging, VO<sub>2</sub> max, entropy, and COVID-19Michael Spedding, Robin Marvaud, Adrien Marck, et al.
British Journal of Pharmacology|January 12, 2002
Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptorsClaude Sebban, Brigitte Tesolin-Decros, Jorge Ciprian-Ollivier, et al.
British Journal of Pharmacology|August 17, 2022
Environmental pharmacology-Dosing the environment: IUPHAR review 36Christopher N Connolly, Stephen P H Alexander, Jamie A Davies, et al.
Neurotoxicity Research|August 25, 2004
Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseasesThérèse M Jay, Cyril Rocher, Maïte Hotte, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Neuropharmacology|September 27, 2008
Ligand gated ion channelsGraham L Collingridge, Richard Olsen, John A Peters, et al.
Brain Research|April 23, 2003
Positive allosteric modulators of AMPA receptors are neuroprotective against lesions induced by an NMDA agonist in neonatal mouse brainEleni Dicou, Claire-Marie Rangon, Fabien Guimiot, et al.
Biochemical Pharmacology|July 2, 2017
Joint ICMAN and IUPHAR natural products section meeting. Aberdeen UK 27-29th September 2017Yongxiang Zhang, Michael Spedding, Cherry Wainwright, et al.
Nature Reviews. Drug Discovery|June 3, 2005
A pathophysiological paradigm for the therapy of psychiatric diseaseMichael Spedding, Thérèse Jay, Jorge Costa e Silva, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 22, 2013
The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?Bill P Godsil, Janos P Kiss, Michael Spedding, et al.
European Journal of Pharmacology|August 23, 2002
Role of spin trapping and P2Y receptor antagonism in the neuroprotective effects of 2,2'-pyridylisatogen tosylate and related compoundsKevin Menton, Michael Spedding, Pierre Gressens, et al.
Indian Journal of Pharmacology|March 28, 2022
Aging, VO<sub>2</sub> max, entropy, and COVID-19Michael Spedding, Robin Marvaud, Adrien Marck, et al.
British Journal of Pharmacology|January 12, 2002
Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptorsClaude Sebban, Brigitte Tesolin-Decros, Jorge Ciprian-Ollivier, et al.
British Journal of Pharmacology|August 17, 2022
Environmental pharmacology-Dosing the environment: IUPHAR review 36Christopher N Connolly, Stephen P H Alexander, Jamie A Davies, et al.
Neurotoxicity Research|August 25, 2004
Plasticity at hippocampal to prefrontal cortex synapses is impaired by loss of dopamine and stress: importance for psychiatric diseasesThérèse M Jay, Cyril Rocher, Maïte Hotte, et al.
Pageof 13